Based on the expression status of the estrogen receptor (ER-a), progesterone receptor (PR) and human epidermal growth factor 2 receptor (HER2/ERBB2), breast cancer is classified as luminal A, luminal B, HER2 positive and TNBC [2]. This evidence concerns the gene ESR1 and breast carcinoma.